secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2024-03-08T23:59:59+00:00
Accession:  0001193805-24-000341
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunic stockholders approve increase in authorized shares from 130M to 500M at special meeting
--------------------------------------------------------------------------------

- Shareholders approved amendment to certificate of incorporation to increase authorized common stock from 130M to 500M shares.
- Approved amendment to 2021 ESPP increasing reserved shares by 1M to 1.2M shares.
- Approved amendment to 2019 Omnibus Equity Plan increasing authorized shares by 9.1M to 19.4M shares.
- Approved repricing of stock options with exercise price above $3.00 to greater of $1.72 or 110% of future closing price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380524000341/0001193805-24-000341-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380524000341/e619340_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-24-000341

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer